Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT00884169
Eligibility Criteria:
Inclusion Criteria:
* Who are able and willing to give signed informed consent
* Who are male or females aged between 18 and 65 years with plaque psoriasis confirmed by the Investigator.
* Who have less than 20% of body surface area (BSA) afflicted with plaques
* Who are neither pregnant nor breast-feeding, nor plan to become pregnant during the study.
Exclusion Criteria:
* Who have a history of allergy to vitamin D3 derivative preparations.
* Who have a history of relevant drug hypersensitivity.
* Who have a history of contact dermatitis induced by a topical medicine.
* Who are pregnant or lactating.
* Who have any renal or hepatic insufficiency, or clinically significant cardiac, renal or hepatic disease.
* Who have clinically relevant history or presence of any disease or surgical history other than psoriasis which is likely to affect the conduct of the study.
* Whose serum calcium levels exceed the upper limit of reference range
* Who have used any investigational medicinal product and/or participated in any clinical study within 24 weeks
* Who have been treated with systemic therapy within 8 weeks
* Who have been treated with biologics within 12 weeks
* Who have been treated with topical therapy during the wash-out and lead-in period.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00884169
Study Brief:
Protocol Section:
NCT00884169